LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 167

Search options

  1. Article ; Online: Percutaneous transfistulous interventions for intractable pancreatic fistula.

    Hirota, Masahiko

    Radiology research and practice

    2011  Volume 2011, Page(s) 109259

    Abstract: THREE TECHNIQUES FOR THE TREATMENT OF INTRACTABLE PANCREATIC FISTULA: percutaneous transfistulous pancreatic duct drainage (PTPD), percutaneous transfistulous pancreatojejunostomy (PTPJ), and percutaneous transfistulous pancreatic duct embolization (PTPE) ...

    Abstract THREE TECHNIQUES FOR THE TREATMENT OF INTRACTABLE PANCREATIC FISTULA: percutaneous transfistulous pancreatic duct drainage (PTPD), percutaneous transfistulous pancreatojejunostomy (PTPJ), and percutaneous transfistulous pancreatic duct embolization (PTPE) are presented as treatment options for intractable pancreatic fistula. PTPD is effective for most cases of intractable fistula that communicate with the main pancreatic duct. However, PTPD itself is not enough in some specific cases. PTPJ and PTPE are applicable in such cases.
    Language English
    Publishing date 2011-03-30
    Publishing country Egypt
    Document type Journal Article
    ZDB-ID 2594649-3
    ISSN 2090-195X ; 2090-1941
    ISSN (online) 2090-195X
    ISSN 2090-1941
    DOI 10.1155/2011/109259
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Acute pancreatitis. 2. Etiology and physiopathology].

    Hirota, Masahiko

    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

    2010  Volume 99, Issue 1, Page(s) 9–14

    MeSH term(s) Acute Disease ; Female ; Humans ; Male ; Pancreatitis/etiology ; Pancreatitis/physiopathology
    Language Japanese
    Publishing date 2010-01-13
    Publishing country Japan
    Document type Journal Article ; Review
    ZDB-ID 952816-7
    ISSN 1883-2083 ; 0021-5384
    ISSN (online) 1883-2083
    ISSN 0021-5384
    DOI 10.2169/naika.99.9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A case of accessory hepatic duct entering cystic duct successfully treated by laparoscopic cholecystectomy for cholecystolithiasis.

    Tomita, Masahiro / Okabe, Hirohisa / Masuda, Toshiro / Ono, Asuka / Kuroda, Daisuke / Kuroki, Hideyuki / Hirota, Masahiko / Hibi, Taizo / Baba, Hideo / Sugita, Hiroki

    Asian journal of endoscopic surgery

    2023  Volume 16, Issue 3, Page(s) 546–549

    Abstract: Although laparoscopic cholecystectomy is a well-established surgical procedure, an accessory hepatic duct (AcHD) entering the cystic duct is poorly understood. A 77-year-old woman with symptomatic cholecystlithiasis was referred to our hospital. ... ...

    Abstract Although laparoscopic cholecystectomy is a well-established surgical procedure, an accessory hepatic duct (AcHD) entering the cystic duct is poorly understood. A 77-year-old woman with symptomatic cholecystlithiasis was referred to our hospital. Abdominal ultrasonography indicated several small stones in the gall bladder. Magnetic resonance cholangiopancreatography (MRCP) did not reveal an anomalous cystic duct. Dissecting the gall bladder bed at operation, AcHD entering the cystic duct was suspected. Intraoperative cholangiography revealed that B5 branch entered the cystic duct. We ligated the AcHD, and divided it. Laparoscopic cholecystectomy was completed, and the patient was discharged without any complication. A week after the operation, MRCP showed that ventral branch of B5 was dilated. The patient showed no symptom for more than a year. The present case exhibited extremely rare AcHD entering the cystic duct, which was hardly recognized before surgery. It is possible to recognize such anomalous variants with standard laparoscopic approach based on 2018 Tokyo Guidelines and with attention to the possibilities of AcHD entering the cystic duct.
    MeSH term(s) Female ; Humans ; Aged ; Cystic Duct/surgery ; Cholecystectomy, Laparoscopic/methods ; Cholecystolithiasis/complications ; Cholecystolithiasis/surgery ; Hepatic Duct, Common/surgery ; Cholangiography
    Language English
    Publishing date 2023-03-21
    Publishing country Japan
    Document type Case Reports
    ZDB-ID 2503256-2
    ISSN 1758-5910 ; 1758-5902
    ISSN (online) 1758-5910
    ISSN 1758-5902
    DOI 10.1111/ases.13175
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Combined Neutrophil-to-Lymphocyte Ratio Score Is Associated With Chemotherapeutic Response and Predicts Prognosis in Patients With Advanced Pancreatic Cancer.

    Okabe, Hirohisa / Masuda, Toshiro / Tomita, Masahiro / Ono, Asuka / Ogawa, Daisuke / Kuroda, Daisuke / Kuroki, Hideyuki / Hirota, Masahiko / Hibi, Taizo / Baba, Hideo / Sugita, Hiroki

    Anticancer research

    2024  Volume 44, Issue 4, Page(s) 1575–1582

    Abstract: Background/aim: Neutrophil-to-lymphocyte ratio (NLR) is a prognostic indicator for several malignancies, including pancreatic cancer. We developed a novel combined NLR score (cNLRS) based on baseline NLR and change in NLR after chemotherapy (ΔNLR), and ... ...

    Abstract Background/aim: Neutrophil-to-lymphocyte ratio (NLR) is a prognostic indicator for several malignancies, including pancreatic cancer. We developed a novel combined NLR score (cNLRS) based on baseline NLR and change in NLR after chemotherapy (ΔNLR), and examined its prognostic value and role in chemotherapeutic response in patients with advanced pancreatic cancer.
    Patients and methods: This study retrospectively assessed 210 advanced pancreatic cancer patients receiving chemotherapy between 2010 and 2021. The cNLRS was developed and its association with chemotherapeutic response and prognosis was investigated.
    Results: The cNLRS consisted of baseline NLR ≥2.5 and ΔNLR ≥0, both of which were remained as independent poor predictors of prognosis adjusting for other traditional clinicopathological features. A high cNLRS served as an independent prognostic factor of reduced overall survival. Of note, the cNLRS was significantly associated with disease control rate and treatment duration not only in 1st line treatment but also in 2nd line treatment.
    Conclusion: The cNLRS established as a useful prognostic biomarker might be associated with chemotherapeutic response and could predict survival in advanced patients with pancreatic ductal adenocarcinoma treated with chemotherapy.
    MeSH term(s) Humans ; Neutrophils/pathology ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Prognosis ; Lymphocytes/pathology ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/pathology
    Language English
    Publishing date 2024-03-27
    Publishing country Greece
    Document type Journal Article
    ZDB-ID 604549-2
    ISSN 1791-7530 ; 0250-7005
    ISSN (online) 1791-7530
    ISSN 0250-7005
    DOI 10.21873/anticanres.16955
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution.

    Sugita, Hiroki / Okabe, Hirohisa / Ogawa, Daisuke / Hirao, Hiroki / Kuroda, Daisuke / Taki, Katsunobu / Tomiyasu, Shinjiro / Hirota, Masahiko

    BMC surgery

    2022  Volume 22, Issue 1, Page(s) 367

    Abstract: Background: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term ... ...

    Abstract Background: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum CA19-9 levels were associated with POPF in PDAC patients.
    Methods: This cohort study was conducted at a single institution retrospectively. Clinicopathologic features were determined using medical records.
    Results: Among of 196 consecutive patients who underwent pancreatectomy against PDAC, 180 patients whose CA19-9 levels were above the measurement sensitivity, were registered in this study. The patients consisted of 122 patients who underwent pancreaticoduodenectomy and 58 patients who underwent distal pancreatectomy. Several clinicopathological factors, including CA 19-9 level, as well as surgical factors were determined retrospectively based on the medical records. Patients with high CA19-9 levels had a significantly higher incidence of POPF than those with low levels (43.9 vs. 13.0%, P < 0.0001). The receiver operating characteristic curves calculated that the cutoff CA19-9 value to predict POPF was 428 U/mL. CA19-9, BMI, curability, and histology were statistically significant risk factors for POPF by univariate analysis. Multivariate analysis showed that CA19-9 and BMI levels were statistically significant independent risk factors for POPF. CA19-9 levels were correlated with both histology and curability. Disease free survival and overall survival of patients with higher levels of CA19-9 were significantly shorter than that of patients with lower levels of preoperative serum CA19-9.
    Conclusions: In patients undergoing pancreatectomy for PDAC, higher preoperative CA19-9 levels are a significant predictor for POPF.
    MeSH term(s) Humans ; Pancreatic Fistula/diagnosis ; Pancreatic Fistula/etiology ; Pancreatic Fistula/surgery ; CA-19-9 Antigen ; Retrospective Studies ; Cohort Studies ; Carcinoma, Pancreatic Ductal/surgery ; Carcinoma, Pancreatic Ductal/pathology ; Pancreatic Neoplasms/pathology ; Pancreaticoduodenectomy/adverse effects ; Pancreatectomy/adverse effects ; Postoperative Complications/diagnosis ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Risk Factors ; Pancreatic Neoplasms
    Chemical Substances CA-19-9 Antigen
    Language English
    Publishing date 2022-10-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2050442-1
    ISSN 1471-2482 ; 1471-2482
    ISSN (online) 1471-2482
    ISSN 1471-2482
    DOI 10.1186/s12893-022-01825-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: No-touch pancreatectomy for invasive ductal carcinoma of the pancreas.

    Hirota, Masahiko / Ogawa, Michio

    JOP : Journal of the pancreas

    2014  Volume 15, Issue 3, Page(s) 243–249

    Abstract: Background: Pancreatectomy is the only effective treatment for cancers of the pancreas. Surgeons usually grasp tumors during pancreatectomy; however, this procedure may increase the risk of squeezing and shedding of the cancer cells into the portal vein, ...

    Abstract Background: Pancreatectomy is the only effective treatment for cancers of the pancreas. Surgeons usually grasp tumors during pancreatectomy; however, this procedure may increase the risk of squeezing and shedding of the cancer cells into the portal vein, retroperitoneum, and/or peritoneal cavity. In an effort to overcome these problems, we have developed surgical techniques for no-touch pancreatectomy.
    Methods: From April 2008 through September 2013, 52 patients have been operated on no-touch pancreatectomy for invasive ductal carcinoma of the pancreas by a single operator (M.H.). Among them, 40 received pancreatoduodenectomy (PD), and 12 did distal pancreatectomy (DP). Twenty two cases (42%) required SMV-PV resection. This is a study to see if pancreatectomy can be technically done using a no-touch surgical technique without deteriorating the post-operative prognosis. During the procedure, the pancreatic tumor is neither grasped nor squeezed by the surgeon. Furthermore, for improved dissection of the retroperitoneal tissue (leftward and posterior margins for PD and rightward and posterior margins for DP), we use a hanging and clamping maneuver and dissection behind Gerota fascia.
    Results: Overall 2- and 5-year survival rates were 64 and 42% with mean follow-up periods of 34.4 months (range: 6-68 months). Recurrence free 2- and 5-year survival rates were 49 and 31%, respectively. The 5-year survival rates of patients with JPS-stage III and those with JPS-stage IV were 57 and 20%, respectively. The 5-year survival rates of patients with UICC-stage IIA and those with UICC- stage IIB were 49 and 39%, respectively. Patients with UICC-stage III or IV did not survive for more than 2 years.
    Conclusions: No-touch pancreatectomy has many theoretic advantages that merit further investigation in future randomized controlled trials.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Carcinoma, Pancreatic Ductal/mortality ; Carcinoma, Pancreatic Ductal/secondary ; Carcinoma, Pancreatic Ductal/surgery ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Invasiveness/pathology ; Neoplasm Invasiveness/prevention & control ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Neoplastic Cells, Circulating/pathology ; Pancreatectomy/adverse effects ; Pancreatectomy/methods ; Pancreatectomy/mortality ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/surgery ; Prognosis ; Retroperitoneal Space/surgery ; Surgical Instruments ; Touch
    Language English
    Publishing date 2014-05-27
    Publishing country Italy
    Document type Clinical Trial ; Journal Article
    ZDB-ID 2039637-5
    ISSN 1590-8577 ; 1590-8577
    ISSN (online) 1590-8577
    ISSN 1590-8577
    DOI 10.6092/1590-8577/2502
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Roles of Autophagy and Pancreatic Secretory Trypsin Inhibitor in Trypsinogen Activation in Acute Pancreatitis.

    Hirota, Masahiko / Ohmuraya, Masaki / Hashimoto, Daisuke / Suyama, Koichi / Sugita, Hiroki / Ogawa, Michio

    Pancreas

    2020  Volume 49, Issue 4, Page(s) 493–497

    Abstract: The focus of the review is on roles of autophagy and pancreatic secretory trypsin inhibitor (PSTI), an endogenous trypsin inhibitor, in trypsinogen activation in acute pancreatitis. Acute pancreatitis is a disease in which tissues in and around the ... ...

    Abstract The focus of the review is on roles of autophagy and pancreatic secretory trypsin inhibitor (PSTI), an endogenous trypsin inhibitor, in trypsinogen activation in acute pancreatitis. Acute pancreatitis is a disease in which tissues in and around the pancreas are autodigested by pancreatic digestive enzymes. This reaction is triggered by the intrapancreatic activation of trypsinogen. Autophagy causes trypsinogen and cathepsin B, a trypsinogen activator, to colocalize within the autolysosomes. Consequently, if the resultant trypsin activity exceeds the inhibitory activity of PSTI, the pancreatic digestive enzymes are activated, and they cause autodigestion of the acinar cells. Thus, autophagy and PSTI play important roles in the development and suppression of acute pancreatitis, respectively.
    MeSH term(s) Acinar Cells/pathology ; Animals ; Autophagy/physiology ; Cathepsin B/metabolism ; Disease Models, Animal ; Endoplasmic Reticulum Stress ; Enzyme Activation ; Glycoproteins/deficiency ; Humans ; Lysosomes/enzymology ; Mice ; Mice, Knockout ; Molecular Chaperones/physiology ; Pancreatitis/enzymology ; Pancreatitis/metabolism ; Pancreatitis/pathology ; Prostatic Secretory Proteins ; Protein Folding ; Proteolysis ; Secretory Vesicles/enzymology ; Transcription Factor CHOP/deficiency ; Trypsin Inhibitor, Kazal Pancreatic/deficiency ; Trypsin Inhibitor, Kazal Pancreatic/physiology ; Trypsinogen/metabolism
    Chemical Substances Ddit3 protein, mouse ; Glycoproteins ; Molecular Chaperones ; Prostatic Secretory Proteins ; SPINK1 protein, human ; Spink1 protein, mouse ; Transcription Factor CHOP (147336-12-7) ; Trypsin Inhibitor, Kazal Pancreatic (50936-63-5) ; Trypsinogen (9002-08-8) ; CTSB protein, human (EC 3.4.22.1) ; Cathepsin B (EC 3.4.22.1)
    Language English
    Publishing date 2020-04-16
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 632831-3
    ISSN 1536-4828 ; 0885-3177
    ISSN (online) 1536-4828
    ISSN 0885-3177
    DOI 10.1097/MPA.0000000000001519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: [Various mediators of acute pancreatitis and the mechanism of their activation].

    Hirota, Masahiko

    Nihon rinsho. Japanese journal of clinical medicine

    2004  Volume 62, Issue 11, Page(s) 1966–1970

    MeSH term(s) Acute Disease ; Animals ; Cytokines/metabolism ; Disease Progression ; Endotoxemia ; Humans ; Inflammation Mediators/metabolism ; Leukocyte Elastase/physiology ; Multiple Organ Failure/etiology ; Pancreatitis/etiology ; Receptor, PAR-2/physiology ; Severity of Illness Index ; Trypsin/metabolism ; Trypsinogen/metabolism
    Chemical Substances Cytokines ; Inflammation Mediators ; Receptor, PAR-2 ; Trypsinogen (9002-08-8) ; Leukocyte Elastase (EC 3.4.21.37) ; Trypsin (EC 3.4.21.4)
    Language Japanese
    Publishing date 2004-11
    Publishing country Japan
    Document type Journal Article ; Review
    ZDB-ID 390903-7
    ISSN 0047-1852
    ISSN 0047-1852
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Construction and validation of a simple scoring system for stage III colorectal cancer recurrence (SiS-SCORE). A case control study.

    Ishikawa, Shinji / Sawayama, Hiroshi / Matsuo, Akinobu / Uchino, Ryojin / Honda, Shinobu / Hirota, Masahiko / Baba, Hideo

    Japanese journal of clinical oncology

    2019  Volume 49, Issue 3, Page(s) 238–244

    Abstract: Background: Stage III colorectal cancer is an indication for adjuvant chemotherapy; however, there is no definite view on the selection of regimen. If the recurrence can be predicted, it can serve as the indicator of regimen selection. The present study ...

    Abstract Background: Stage III colorectal cancer is an indication for adjuvant chemotherapy; however, there is no definite view on the selection of regimen. If the recurrence can be predicted, it can serve as the indicator of regimen selection. The present study aimed to predict the recurrence of stage III colorectal cancer by constructing a simple scoring system.
    Methods: The information of stage III cases that underwent curative surgery was obtained from two facilities and analyzed. A scoring system was constructed from the analysis results and evaluated based on the cases from a different facility.
    Results: Five factors were extracted by multivariate analysis: age > 65, male, rectum, ≥pN2 and CA19-9 > 37. When these parameters were scored as 1 point each, the score was correlated with the cumulative recurrence rate. Additionally, when cases were divided into three groups (≤1 point, 2 points, ≥3 points), the 5-year recurrence rate was as follows:, ≤1 point: 33.3%, 2 points: 42.1%, ≥3 points: 78.6%. The cumulative recurrence rate of ≥3 points was significantly higher than that of ≤1 point (P < 0.001). Similar results were obtained by evaluating that cases at a different facility (P = 0.032). Both cases with 2 points were located between ≤1 point and ≥3 points, reflecting the average recurrence rate of each institution.
    Conclusion: As the SiS-SCORE presented the same result in the facility that was different from the base facility, it can be used widely. However, a prospective study is required to prove the usefulness of the SiS-SCORE.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Colorectal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prospective Studies
    Language English
    Publishing date 2019-01-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 190978-2
    ISSN 1465-3621 ; 0368-2811
    ISSN (online) 1465-3621
    ISSN 0368-2811
    DOI 10.1093/jjco/hyy192
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Innovations in pancreatic surgery.

    Hirota, Masahiko / Sand, Juhani / Segersvärd, Ralf / Cirocchi, Roberto

    BioMed research international

    2014  Volume 2014, Page(s) 963416

    MeSH term(s) Digestive System Surgical Procedures/instrumentation ; Digestive System Surgical Procedures/methods ; Digestive System Surgical Procedures/trends ; Humans ; Pancreas/surgery
    Language English
    Publishing date 2014-07-21
    Publishing country United States
    Document type Editorial
    ZDB-ID 2698540-8
    ISSN 2314-6141 ; 2314-6133
    ISSN (online) 2314-6141
    ISSN 2314-6133
    DOI 10.1155/2014/963416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top